Know Cancer

or
forgot password

Phase I Study to Assess the Safety and Tolerability of AZD5438 in Patients With Advanced Solid Malignancies


Phase 1
18 Years
N/A
Not Enrolling
Both
Neoplasms

Thank you

Trial Information

Phase I Study to Assess the Safety and Tolerability of AZD5438 in Patients With Advanced Solid Malignancies


Inclusion Criteria:



- Advanced solid malignancy

- Cancer refractory to standard treatments or for which no standard therapy exits

Exclusion Criteria:

- Radiotherapy within 3 weeks of the start of treatment

- Investigational product within the last 3 weeks

- Systemic cytotoxic anti-cancer therapy within the last 3 weeks

- Any significant clinical disorder that makes it undesirable for the patient to
participate

Type of Study:

Interventional

Study Design:

Primary Purpose: Treatment

Authority:

United States: Food and Drug Administration

Study ID:

D0110C00005

NCT ID:

NCT00088790

Start Date:

July 2004

Completion Date:

December 2005

Related Keywords:

  • Neoplasms
  • advanced, solid, malignancies
  • Neoplasms

Name

Location

Research SiteBeverly, Massachusetts  
Research SiteAlbany, New York